U.S. flag An official website of the United States government
  1. Home
  2. For Health Professionals
  3. Learning Activities
  1. For Health Professionals

CDERLearn in the Center for Drug Evaluation and Research (CDER) offers a variety of learning opportunities for healthcare professionals, industry, consumers, and academia. The goal is to create a body of educational and information modules about human drug regulation and activities. CDERLearn is a way to share FDA expertise in specific subject areas to further instruct the public about the many ways CDER protects and promotes public health. CDERLearn

Sub-Topic Paragraphs

Latest From the Commissioner

Remarks by Commissioner Robert M. Califf, M.D. at the FDA-U.S. Patent and Trademark Office Public Workshop - 01/19/2023

Jan 19

FDA Provides Update on External Evaluation to Strengthen Agency’s Tobacco Program

Dec 19

Coronavirus (COVID-19) Update: FDA to Hold Advisory Committee Meeting to Discuss Future Vaccination Regimens Addressing COVID-19

Dec 16

FDA Provides Update on External Evaluation to Strengthen Agency’s Human Foods Program

Dec 06

La FDA impulsa la innovación para los alimentos de consumo humano a partir de la tecnología de cultivo de células animales

Nov 16

FDA Spurs Innovation for Human Food from Animal Cell Culture Technology

Nov 16

FDA Commissioner Tests Positive for COVID-19; Experiencing Mild Symptoms

Nov 07

Remarks by FDA Commissioner Robert Califf to the 2022 Inter-governmental Working Meeting on Drug Compounding - 11/01/2022

Nov 02

Stakeholder Update

FDA's Stakeholder Engagement Staff works to provide you with up-to-date information that helps to further our commitment in advancing public health and well-being.

Back to Top